[
  {
    "ts": "2025-11-13T10:15:00+00:00",
    "headline": "Here Are the Top Growth Healthcare Stocks Every New Investor Should Know",
    "summary": "These top growth stocks have plenty of room left to run.",
    "url": "https://www.fool.com/investing/2025/11/13/here-are-the-top-growth-healthcare-stocks-every-ne/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "693ca2d1-1d15-3d83-b4b1-ec67bd4f8838",
      "content": {
        "id": "693ca2d1-1d15-3d83-b4b1-ec67bd4f8838",
        "contentType": "STORY",
        "title": "Here Are the Top Growth Healthcare Stocks Every New Investor Should Know",
        "description": "",
        "summary": "These top growth stocks have plenty of room left to run.",
        "pubDate": "2025-11-13T10:15:00Z",
        "displayTime": "2025-11-13T10:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab",
          "originalWidth": 1400,
          "originalHeight": 978,
          "caption": "professional thoughtful investor ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0zgFcCdo1wBatd4Z_KJgfg--~B/aD05Nzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab.cf.webp",
              "width": 1400,
              "height": 978,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FJAvhMuIQ0.26A5wB2Z4XQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/here-are-the-top-growth-healthcare-stocks-every-ne/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-growth-healthcare-stocks-every-101500662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T12:00:00+00:00",
    "headline": "Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs",
    "summary": "Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this setting Additional oral presentation spotlights data for odronextamab in combination with chemotherapy, without rituximab, as a frontline treatment for diffuse large B-cell lymphoma Other presentations span a broad range of hematologic conditions, including paroxysmal nocturnal hemoglobinuria and severe",
    "url": "https://finance.yahoo.com/news/regeneron-highlights-progress-american-society-120000711.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "a47315f6-1b0a-3501-a5a6-a3c114e1ee1f",
      "content": {
        "id": "a47315f6-1b0a-3501-a5a6-a3c114e1ee1f",
        "contentType": "STORY",
        "title": "Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs",
        "description": "",
        "summary": "Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this setting Additional oral presentation spotlights data for odronextamab in combination with chemotherapy, without rituximab, as a frontline treatment for diffuse large B-cell lymphoma Other presentations span a broad range of hematologic conditions, including paroxysmal nocturnal hemoglobinuria and severe",
        "pubDate": "2025-11-13T12:00:00Z",
        "displayTime": "2025-11-13T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142",
          "originalWidth": 800,
          "originalHeight": 126,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ohIVokMiKClSVTQVwyB2lw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 800,
              "height": 126,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YuYzNeQcIK6rRYN1HdT6UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-highlights-progress-american-society-120000711.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-highlights-progress-american-society-120000711.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]